BCHE and early-onset autosomal dominant Alzheimer disease: The cholinergic deficit in Alzheimer’s disease is a well-known phenomenon, and the restoration of cholinergic function by inhibiting the (acetylcholinesterase) AChE and butyrylcholinesterase (BChE) activity is an effective treatment strategy for Alzheimer’s disease.